Imaging assessment of natalizumab in multiple sclerosis: preliminary results on MRI/MRS and PET data

被引：0
|
作者：
Detour, J. [1 ]
Namer, I-J. [1 ]
Kremer, S. [1 ]
De Seze, J. [1 ]
机构：
[1] Univ Hosp, Strasbourg, France
来源：
MULTIPLE SCLEROSIS JOURNAL | 2011年 / 17卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P845
引用
收藏
页码：S376 / S377
页数：2
相关论文
共 50 条
  • [21] The effectiveness of Natalizumab on MRI outcome measures in patients with relapsing multiple sclerosis
    Dalton, C
    Barker, G
    MacManus, D
    Miszkiel, K
    Bates, D
    Blumhardt, L
    Hawkins, C
    Palace, J
    Sharief, M
    Swingler, R
    Young, C
    Miller, D
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2003, 74 (03): : 399 - 399
  • [22] Results of clinical and magnetic resonance imaging analyses following cessation of natalizumab dosing in patients with multiple sclerosis
    O'Connor, P. W.
    Goodman, A.
    Kappos, L.
    Lublin, F. D.
    Miller, D. H.
    Polman, C. H.
    Rudick, R. A.
    Lynn, F.
    Panzara, M. A.
    Sandrock, W.
    MULTIPLE SCLEROSIS, 2006, 12 : S17 - S18
  • [23] Contribution of cervical cord MRI and brain magnetization transfer imaging to the assessment of individual patients with multiple sclerosis:: a preliminary study
    Rovaris, M
    Holtmannspötter, M
    Rocca, MA
    Iannucci, G
    Codella, M
    Viti, B
    Campi, A
    Comi, G
    Yousry, TA
    Filippi, M
    MULTIPLE SCLEROSIS JOURNAL, 2002, 8 (01) : 52 - 58
  • [24] Multiple sclerosis and headache: preliminary results
    Sorgun, M.
    Yucesan, C.
    MULTIPLE SCLEROSIS, 2007, 13 : S124 - S124
  • [25] MRI and assessment of treatment in multiple sclerosis
    Miller, DH
    Thompson, AJ
    Kappos, L
    BRAIN, 2001, 124 : 1052 - 1053
  • [26] FDG PET/CT and MRI in multiple myeloma patients: preliminary results of the IMAJEM study
    Kraeber-Bodere, Francoise
    Bodet-Milin, Caroline
    Berriolo-riedinger, Alina
    Devaux, Jean-yves
    Huglo, Damien
    Giammarile, Francesco
    Dupas, Benoit
    Nguyen, Jean-Michel
    Attal, Michel
    Moreau, Philippe
    JOURNAL OF NUCLEAR MEDICINE, 2015, 56 (03)
  • [27] An integrated MRI and MRS approach to evaluation of multiple sclerosis with cognitive impairment
    Liang, Zhengrong
    Li, Lihong
    Lu, Hongbing
    Huang, Wei
    Tudorica, Alina
    Krupp, Lauren
    MEDICAL BIOMETRICS, PROCEEDINGS, 2007, 4901 : 200 - +
  • [28] Natalizumab treatment of multiple sclerosis in Spain: results of an extensive observational study
    O. Fernández
    C. Oreja-Guevara
    R. Arroyo
    G. Izquierdo
    J. L. Pérez
    X. Montalban
    Journal of Neurology, 2012, 259 : 1814 - 1823
  • [29] Complete clinical and magnetic resonance imaging response with natalizumab in multiple sclerosis
    Confavreux, C.
    Galetta, S. L.
    Giovannoni, G.
    Havrdova, E.
    Hutchinson, M.
    Lublin, F. D.
    O'Connor, P. W.
    Phillips, J. T.
    Polman, C. H.
    Rudick, R. A.
    Pace, A.
    Hyde, R.
    Panzara, M. A.
    JOURNAL OF NEUROLOGY, 2008, 255 : 37 - 37
  • [30] The immunogenicity of natalizumab in patients with multiple sclerosis: Results from the AFFIRM study
    Giovannoni, G.
    O'Connor, P. W.
    Havrdova, E.
    Hutchinson, M.
    Kappos, L.
    Miller, D. H.
    Phillips, J. T.
    Polman, C. H.
    Lublin, F. D.
    Wajgt, A.
    Lynn, F.
    Panzara, M. A.
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2007, 78 (02): : 208 - 208
12345